parathyroid hormone analogue
Teriparatide dose
Answer
FDA label for Forteo: Recommended dosage is 20 mcg subcutaneously once a day Consider supplemental calcium and Vitamin D based on individual patient needs Administer as a subcutaneous injection into the thigh or abdominal region Administer initially under circumstances in which the patient can sit or lie down if symptoms of orthostatic hypotension occur Use of FORTEO for more than 2 years during a patient's lifetime should only be considered if a patient remains at or has returned to having a high risk for fracture 2.1 Recommended Dosage The recommended dosage is 20 mcg per dose given subcutaneously once a day. Trials with posted results tested 4 doses, most often 20 mcg, 80 mcg, 30 mcg.
Not dosing advice.
FDA LABEL
What the approved labels state
Forteo NDA021318 · label of 2026-08-03 Regulator
Recommended dosage is 20 mcg subcutaneously once a day Consider supplemental calcium and Vitamin D based on individual patient needs Administer as a subcutaneous injection into the thigh or abdominal region Administer initially under circumstances in which the patient can sit or lie down if symptoms of orthostatic hypotension occur Use of FORTEO for more than 2 years during a patient's lifetime should only be considered if a patient remains at or has returned to having a high risk for fracture 2.1 Recommended Dosage The recommended dosage is 20 mcg per dose given subcutaneously once a day.
Teriparatide ANDA213641 · label of 2026-03-12 Regulator
Recommended dosage is 20 mcg subcutaneously once a day Consider supplemental calcium and Vitamin D based on individual patient needs Administer as a subcutaneous injection into the thigh or abdominal region Administer initially under circumstances in which the patient can sit or lie down if symptoms of orthostatic hypotension occur Use of Teriparatide injection for more than 2 years during a patient’s lifetime should only be considered if a patient remains at or has returned to having a high risk for fracture 2.1 Recommended Dosage The recommended dosage is 20 mcg per dose given subcutaneously once a day.
Bonsity NDA211939 · label of 2025-06-01 Regulator
Recommended dosage is 20 mcg subcutaneously once a day Consider supplemental calcium and Vitamin D based on individual patient needs Administer as a subcutaneous injection into the thigh or abdominal region Administer initially under circumstances in which the patient can sit or lie down if symptoms of orthostatic hypotension occur Use of teriparatide for more than 2 years during a patient's lifetime should only be considered if a patient remains at or has returned to having a high risk for fracture 2.1 Recommended Dosage The recommended dosage is 20 mcg given subcutaneously once a day.
IN TRIALS
Doses tested in 63 trials with posted results
| Dose in the arm title | Trials | People on it | Phases |
|---|---|---|---|
| 20 mcg | 4 | 148 | 2/4 |
| 80 mcg | 1 | 64 | 2 |
| 30 mcg | 1 | 56 | 2 |
| 50 mcg | 1 | 54 | 2 |
Trial register Read from the titles of arms that received Teriparatide (n ≥ 20). An arm naming several doses counts under each; a schedule or escalation is on the trial record. All trials.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.